WATERTOWN, Mass.--(BUSINESS WIRE)-- Syros Pharmaceuticals, the leader in the discovery and development of novel gene control therapies for cancer and other serious diseases, announced today that management will participate in two investor conferences during the month of August:
- 2015 Wedbush PacGrow Healthcare Conference, Tuesday, August 11, 2015; Le Parker Meridien Hotel, New York City. Management will present a corporate overview at 8:00 a.m. ET.
- Citi Private Company Healthcare Technology Conference, Tuesday, August 11, 2015; Langham Hotel, Boston.
About Syros Pharmaceuticals
Syros Pharmaceuticals is a therapeutics company harnessing breakthroughs in gene control to revolutionize the treatment of cancer and other diseases. Syros’ proprietary platform identifies the master switches for disease genes, opening a whole new approach to novel therapeutics and biomarkers. The Company’s founders are pioneers in gene control research and translation. Co-founded by Flagship Ventures and ARCH Venture Partners, Syros Pharmaceuticals is located in Watertown, Mass. For more information, visit www.syros.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20150805005085/en/
Ten Bridge Communications, Inc.
Dan Quinn, 781-475-7974
Stern Investor Relations, Inc.
Jesse Baumgartner, 212-362-1200
Source: Syros Pharmaceuticals
Released August 5, 2015